Omalizumab studies confirm that IgE-mediated sensitization to aeroallergens is irrelevant to the clinical outcomes of isolated or asthma-associated CRSwNP, supporting a central role for IgE localized to the airway mucosa. The gene discussed is IGHE; the disease is asthma.